TNNI3 and coronary artery disorder: The development of high sensitivity biomarker assays for cardiac troponin I, which allow the detection of even mildly elevated levels of cardiac troponin in the absence of CAD or a T1MI diagnosis, has made the discrimination between T1MI and T2MI possible.6